Treatment priority shifted to his pancreatic cancer, and he was started on modified fluorouracil/leucovorin/irinotecan (150 mg/m2)/oxaliplatin every 14 days given his PALB2 mutation history.5 This evidence concerns the gene PALB2 and familial pancreatic carcinoma.